Monday, 15 October 2018

OptraSCAN introduces Third Generation On-Demand Digital Pathology® System

15 March 2018 | News

Optra SCAN announced its mass validation and approval from the Government of India for use of its digital pathology system in research and medical settings.

OptraSCAN announced its third generation On-Demand Digital Pathology® system for researchers and clinicians.

The third generation OptraSCAN® brightfield scanner is now able to acquire a whole slide image from a FFPE glass slide in under 60 seconds timeframe at the cost of a traditional digital microscope.

 Dr. Clive Taylor, CMO, OptraSCAN, unveiling 3rd Gen High-Speed & Affordable Scanner in presence of founders Dr. Gauri Naik and Abhi Gholap

CEO Abhi Gholap will be present at USCAP for meetings and personal demonstrations of the On-Demand Digital Pathology suite of solutions. 

Keeping true to its mission statement, OptraSCAN has been working to make digital pathology affordable and accessible to all pathologists worldwide.

The third generation system, with faster scan times, will provide technicians and physicians access to images quickly and help keep their workflow moving at a steady pace.

This next generation system is being unveiled at $20,000 USD price and includes On-Demand Digital Pathology solutions IMAGEPath® image management and TELEPath™ telepathology (amongst others). 

“Our goal at OptraSCAN has always been to build a solution for the global pathology community that removes the bottleneck of price,” said Founder and CEO Abhi Gholap. 

Early this year Optra SCAN announced its mass validation and approval from the Government of India for use of its digital pathology system in research and medical settings.

Going forward, OptraSCAN is in the process of applying for a CE Mark for medical device clearance in the EU.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Click Here!




Survey Box

Can blockchain help cease fake drug distribution in India?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls